Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hip, Knee Replacement Surgeries Raise Heart Attack Risk

By HospiMedica International staff writers
Posted on 08 Aug 2012
Total hip replacement (THR) and total knee replacement (TKR) surgeries were associated with increased risk of an acute heart attack in the first two weeks after the surgical procedures, according to a new study.

Researchers at Utrecht University (The Netherlands), Aarhus University Hospital (Denmark), and other institutions conducted a retrospective, nationwide cohort study within the Danish national registries, identifying 95,227 patients who underwent a primary THR or TKR surgery from January 1, 1998, through December 31, 2007. More...
The patients were matched to three controls (no THR or TKR) by age, sex, and geographic region. All study participants were followed up for acute myocardial infarct (AMI), and disease- and medication history–adjusted hazard ratios (HRs) were calculated.

The results showed that during the first two postoperative weeks, the risk of AMI was substantially increased in THR patients compared with controls. The risk remained elevated for 2-6 weeks after surgery, and then decreased to baseline levels. For TKR patients, AMI risk was also increased during the first 2 weeks, but did not differ from controls after the first two weeks. The absolute six-week risk of AMI was 0.51% in THR patients and 0.21% in TKR patients. The study was published early online on July 23, 2012, in the Archives of Internal Medicine.

“This study demonstrated an increased risk of AMI during the first two weeks after THR (25-fold) and TKR (31-fold) surgery compared with matched controls,” concluded lead author Arief Lalmohamed, PharmD, of Utrecht University and colleagues. “The risk of AMI sharply decreased after this period, although it remained significantly elevated in the first six weeks for THR patients. The association was strongest in patients 80 years or older, whereas we could not detect a significantly increased risk in patients younger than 60 years.”

In THR or TKR patients, the risk of AMI may be decreased or increased shortly after surgery. On one hand, the surgery itself may result in ischemic complications caused by marrow embolization. On the other hand, antithrombotic agents are commonly used in these patients during hospitalization and have the potential to decrease the risk of AMI.

Related Links:

Utrecht University
Aarhus University Hospital




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.